Author

Kate Lynch

Helix (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Assay:electronic health records· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alexandre BolzeiD· 1 shared Amy Curry SturmiD· 1 shared C. Anwar A. ChahaliD· 1 shared Catherine A. HajekiD· 1 shared Chad R. Haldeman-Englert· 1 shared Christopher N. Chapman· 1 shared Daniel Philip JudgeiD· 1 shared Douglas A. Olson· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Alexandre BolzeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Lynch syndrome in the general population: low clinical utility of genomic screening for PMS2 pathogenic variants

Kelly M. Schiabor Barrett, Catherine A. Hajek, James T. Lu, Kate Lynch, Leigha A. Senter, Amy Curry Sturm, Chad R. Haldeman-Englert, Jeremy Cauwels, Douglas A. Stoller, Christopher N. Chapman, C. Anwar A. Chahal, Daniel Philip Judge, Douglas A. Olson, Joseph J. Grzymski, William Lee, , Alexandre Bolze

This study assesses the cancer risk associated with PMS2 pathogenic variants in the general population and finds low clinical utility for genomic screening.

medRxiv · Feb 3, 2025 · PreprintGenetic & Genomic Medicine